These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 28956186)

  • 21. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
    Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D improves diabetic nephropathy in rats by inhibiting renin and relieving oxidative stress.
    Deng X; Cheng J; Shen M
    J Endocrinol Invest; 2016 Jun; 39(6):657-66. PubMed ID: 26691308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomedicine in the treatment of diabetic nephropathy.
    Desai N; Koppisetti H; Pande S; Shukla H; Sirsat B; Ditani AS; Mallick PP; Kathar U; Kalia K; Tekade RK
    Future Med Chem; 2021 Apr; 13(7):663-686. PubMed ID: 33677997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats.
    Bilan VP; Salah EM; Bastacky S; Jones HB; Mayers RM; Zinker B; Poucher SM; Tofovic SP
    J Endocrinol; 2011 Sep; 210(3):293-308. PubMed ID: 21680617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Strategic Investigation on Diabetic Nephropathy; Its Conceptual Model and clinical Manifestations: A Review.
    Wal P; Tyagi S; Pal RS; Yadav A; Jaiswal R
    Curr Diabetes Rev; 2023; 19(5):e260422204036. PubMed ID: 35993472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel reno-protective mechanism of Aspirin involves H2AK119 monoubiquitination and Set7 in preventing type 1 diabetic nephropathy.
    Goru SK; Gaikwad AB
    Pharmacol Rep; 2018 Jun; 70(3):497-502. PubMed ID: 29656179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes.
    Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Chattipakorn SC; Chattipakorn N; Lungkaphin A
    Biomed Pharmacother; 2017 Oct; 94():176-187. PubMed ID: 28759755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Polyphenol in Regulating Oxidative Stress, Inflammation, Fibrosis, and Apoptosis in Diabetic Nephropathy.
    Sapian S; Budin SB; Taib IS; Mariappan V; Zainalabidin S; Chin KY
    Endocr Metab Immune Disord Drug Targets; 2022; 22(5):453-470. PubMed ID: 34802412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms.
    Gnudi L; Coward RJM; Long DA
    Trends Endocrinol Metab; 2016 Nov; 27(11):820-830. PubMed ID: 27470431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.
    Samsu N
    Biomed Res Int; 2021; 2021():1497449. PubMed ID: 34307650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.
    Jacobsen P; Rossing K; Parving HH
    Curr Opin Nephrol Hypertens; 2004 May; 13(3):319-24. PubMed ID: 15073491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy.
    Feng Q; Liu D; Lu Y; Liu Z
    J Immunol Res; 2020; 2020():6193407. PubMed ID: 32411800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy.
    Malek V; Sharma N; Sankrityayan H; Gaikwad AB
    Life Sci; 2019 Mar; 221():159-167. PubMed ID: 30769114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvements in the Management of Diabetic Nephropathy.
    Dounousi E; Duni A; Leivaditis K; Vaios V; Eleftheriadis T; Liakopoulos V
    Rev Diabet Stud; 2015; 12(1-2):119-33. PubMed ID: 26676665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
    Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
    J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress in diabetic nephropathy.
    Kashihara N; Haruna Y; Kondeti VK; Kanwar YS
    Curr Med Chem; 2010; 17(34):4256-69. PubMed ID: 20939814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.